Record NNP B-NP O
date NN I-NP O
: : O O
2077-02-28 CD O B-DATE
ENDOCRINE/DIABETES NNS B-NP O
STAFF NNP I-NP O
CONSULTATION NN I-NP O
Patient NNP B-NP O
: : O O
VAUGHN NNP B-NP I-PATIENT
, , O I-PATIENT
FRANK NNP B-NP I-PATIENT
MANAMANA NNP I-NP B-HOSPITAL
MRN NNP I-NP O
: : O O
6767510 CD O B-MEDICALRECORD
Requesting VBG B-NP O
MD NNP I-NP O
: : O O
Dr. NNP B-NP O
Quale NNP I-NP B-DOCTOR
Service NNP I-NP O
: : O O
SICU NNP B-NP O
CC/ID NNP B-NP O
: : O O
Asked VBN B-VP O
to TO I-VP O
see VB I-VP O
this DT B-NP O
33 CD I-NP B-AGE
y/o NN I-NP O
M NNP I-NP O
admitted VBD B-VP O
with IN B-PP O
Fourier NNP B-NP O
's POS B-NP O
gangrene NN I-NP O
, , O O
s/p VBP B-VP O
multiple JJ B-NP O
surgical JJ I-NP O
procedures NNS I-NP O
, , O O
for IN B-PP O
DM NNP B-NP O
management NN I-NP O
HPI/ROS NNP B-NP O
: : O O
Pt NNP B-NP O
is VBZ B-VP O
a DT B-NP O
33 CD I-NP B-AGE
y/o NN I-NP O
with IN B-PP O
DM-2 DT B-NP O
who WP B-NP O
was VBD B-VP O
in IN B-PP O
his PRP$ B-NP O
USH NNP I-NP O
until IN B-PP O
about IN B-NP O
2 CD I-NP O
weeks NNS I-NP O
PTA NNP I-NP O
, , O O
when WRB B-ADVP O
he PRP B-NP O
developed VBD B-VP O
buttock NN B-NP O
pain NN I-NP O
. . O O
He PRP B-NP O
had VBD B-VP O
some DT B-NP O
purulent JJ I-NP O
D/C NNP I-NP O
from IN B-PP O
rectum NN B-NP O
and CC O O
worsening VBG B-VP O
of IN B-PP O
glucose NN B-NP O
control NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
in IN B-PP O
EDUCARE-PULLMAN NNP B-NP B-HOSPITAL
Urgent NNP I-NP O
Care NNP I-NP O
on IN B-PP O
1/21/77 CD B-NP B-DATE
at IN B-PP O
which WDT B-NP O
time NN I-NP O
a DT B-NP O
small JJ I-NP O
erythematous JJ I-NP O
and CC I-NP O
tender JJ I-NP O
cyst NN I-NP O
was VBD B-VP O
noted VBN I-VP O
between IN B-PP O
his PRP$ B-NP O
buttocks NNS I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
prescribed VBN I-VP O
sitz NN B-NP O
baths NNS I-NP O
and CC O O
Keflex NNP B-NP O
for IN B-PP O
pilonidol NN B-NP O
cyst NN I-NP O
vs. NN I-NP O
ruptured VBD B-VP O
boil NN B-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
again RB B-ADVP O
in IN B-PP O
EDUCARE-PULLMAN NNP B-NP B-HOSPITAL
on IN B-PP O
1/29/77 CD B-NP B-DATE
at IN B-PP O
which WDT B-NP O
time NN I-NP O
he PRP B-NP O
reported VBD B-VP O
resolution NN B-NP O
of IN B-PP O
his PRP$ B-NP O
buttock NN I-NP O
pain NN I-NP O
. . O O
He PRP B-NP O
denied VBD B-VP O
fevers NNS B-NP O
or CC O O
neurologic NN B-NP O
symptoms NNS I-NP O
. . O O
Exam NNP B-NP O
was VBD B-VP O
notable JJ B-ADJP O
for IN B-PP O
only RB B-NP O
a DT I-NP O
tiny JJ I-NP O
pustule NN I-NP O
in IN B-PP O
the DT B-NP O
upper JJ I-NP O
gluteal NN I-NP O
cleft JJ I-NP O
, , O O
minimally RB B-ADVP O
erythematous JJ B-NP O
, , I-NP O
non-tender JJ I-NP O
, , O O
without IN B-PP O
drainage NN B-NP O
. . O O
On IN B-PP O
the DT B-NP O
morning NN I-NP O
of IN B-PP O
2/01/77 CD B-NP B-DATE
he PRP B-NP O
developed VBD B-VP O
worsening VBG I-VP O
of IN B-PP O
his PRP$ B-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
the DT B-NP O
development NN I-NP O
of IN B-PP O
left JJ B-NP O
jaw NN I-NP O
pain NN I-NP O
, , O O
and CC O O
cold JJ B-NP O
sweats NNS I-NP O
, , O O
so RB O O
he PRP B-NP O
presented VBD B-VP O
to TO B-PP O
the DT B-NP O
MANAMANA NNP I-NP B-HOSPITAL
ED. NNP I-NP O
On IN B-PP O
presentation NN B-NP O
, , O O
he PRP B-NP O
also RB B-ADVP O
admitted VBD B-VP O
to TO B-PP O
three CD B-NP O
days NNS I-NP O
of IN B-PP O
scrotal JJ B-NP O
and CC I-NP O
perineal JJ I-NP O
pain NN I-NP O
and CC O O
swelling VBG B-VP O
. . B-NP O
In IN B-PP O
the DT B-NP O
ED NNP I-NP O
he PRP B-NP O
was VBD B-VP O
tachycardic JJ B-ADJP O
to TO B-PP O
113 CD B-NP O
, , O O
normotensive JJ B-ADVP O
, , O O
initially RB B-NP O
low-grade JJ I-NP O
fever NN I-NP O
, , O O
but CC O O
later RB B-VP O
spiked VBN I-VP O
to TO B-PP O
102.9 CD B-NP O
. . O O
On IN B-PP O
examination NN B-NP O
, , O O
there EX B-NP O
was VBD B-VP O
severe JJ B-NP O
bilateral JJ I-NP O
testicular NN I-NP O
swelling VBG I-NP O
and CC I-NP O
pain NN I-NP O
, , O O
with IN B-PP O
a DT B-NP O
fluctuant JJ I-NP O
mass NN I-NP O
between IN B-PP O
the DT B-NP O
rectum NN I-NP O
and CC I-NP O
scrotum NN I-NP O
. . O O
His PRP$ B-NP O
WBC NNP I-NP O
was VBD B-VP O
18,000 CD B-NP O
with IN B-PP O
91 CD B-NP O
% NN I-NP O
PMNs NN I-NP O
. . O O
An DT B-NP O
abdominal NN I-NP O
CT NNP B-NP O
revealed VBD B-VP O
extensive JJ B-NP O
subcutaneous JJ I-NP O
edema NN I-NP O
in IN B-PP O
the DT B-NP O
perineum NN I-NP O
, , O O
with IN B-PP O
multiple JJ B-NP O
foci NNS I-NP O
of IN B-PP O
air NN B-NP O
consistent JJ B-ADJP O
with IN B-PP O
a DT B-NP O
necrotizing JJ I-NP O
infection NN I-NP O
; : O O
and CC O O
extensive JJ B-NP O
fluid NN I-NP O
in IN B-PP O
the DT B-NP O
scrotum NN I-NP O
, , O O
consistent JJ B-ADJP O
with IN B-PP O
Fournier NNP B-NP O
's POS B-NP O
gangrene NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN I-VP O
with IN B-PP O
IV NNP B-NP O
Abx NNP I-NP O
and CC O O
was VBD B-VP O
taken VBN I-VP O
urgently RB B-ADVP O
to TO B-PP O
the DT B-NP O
OR JJ I-NP O
, , O O
where WRB B-ADVP O
he PRP B-NP O
underwent VBD B-VP O
extensive JJ B-NP O
debridement NN I-NP O
at IN B-PP O
which WDT B-NP O
time NN B-NP O
substantial JJ I-NP O
necrosis NN I-NP O
and CC I-NP O
pus FW I-NP O
were VBD B-VP O
discovered VBN I-VP O
. . O O
He PRP B-NP O
was VBD B-VP O
admitted VBN I-VP O
to TO B-PP O
the DT B-NP O
SICU NNP I-NP O
and CC O O
has VBZ B-VP O
since IN I-VP O
undergone VBN I-VP O
multiple JJ B-NP O
debridements NNS I-NP O
, , O O
last JJ B-NP O
on IN B-PP O
2/20/77 CD B-NP B-DATE
. . O O
In IN B-PP O
terms NNS B-NP O
of IN B-PP O
his PRP$ B-NP O
DM NNP I-NP O
, , O O
he PRP B-NP O
has VBZ B-VP O
type NN B-NP O
2 CD I-NP O
diagnosed VBN B-VP O
in IN B-PP O
October NNP B-NP B-DATE
2075 CD I-NP I-DATE
. . O O
At IN B-PP O
the DT B-NP O
time NN I-NP O
he PRP B-NP O
was VBD B-VP O
feeling VBG I-VP O
"lousy JJ B-ADJP O
, , O O
" '' O O
tired VBN B-VP O
, , O O
nauseated VBN B-VP O
, , O O
and CC O O
increased VBD B-VP O
urinary JJ B-NP O
frequency NN I-NP O
: : O O
went VBD B-VP O
to TO B-PP O
Payson NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
and CC O O
FS NNP B-NP O
was VBD B-VP O
376 CD B-NP O
. . O O
Pt NNP B-NP O
was VBD B-VP O
admitted VBN I-VP O
overnight JJ B-NP O
and CC I-NP O
given VBN I-NP O
insulin NN I-NP O
; : O O
started VBD B-NP O
on IN B-PP O
Metformin NNP B-NP O
500 CD I-NP O
bid NN I-NP O
, , O O
eventually RB B-ADVP O
insulin NN B-NP O
was VBD B-VP O
added VBN I-VP O
. . O O
He PRP B-NP O
was VBD B-VP O
being VBG I-VP O
followed VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Talley NNP I-NP B-DOCTOR
at IN B-PP O
the DT B-NP O
Promptcare NNP I-NP B-HOSPITAL
but CC O O
stopped VBD B-VP O
going VBG I-VP O
there RB B-ADVP O
. . O O
Most RBS B-ADVP O
recently RB I-ADVP O
treated VBN B-NP O
with IN B-PP O
Lantus RB B-NP O
50 CD I-NP O
units NNS I-NP O
at IN B-PP O
bedtime NN B-NP O
plus CC O O
maximal JJ B-NP O
doses NNS I-NP O
of IN B-PP O
Glipizide NNP B-NP O
10 CD I-NP O
bid NN I-NP O
and CC O O
Metformin NNP B-NP O
1000 CD I-NP O
bid NN I-NP O
, , O O
with IN B-PP O
uncontrolled JJ B-NP O
HbA1c JJ I-NP O
( -LRB- I-NP O
see VBP B-VP O
below IN B-PP O
) -RRB- B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
microalbuminuria NNS B-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
unable JJ B-ADJP O
to TO B-VP O
give VB I-VP O
me PRP B-NP O
a DT B-NP O
full JJ I-NP O
history NN I-NP O
. . O O
In IN B-PP O
the DT B-NP O
SICU NNP I-NP O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
treated VBN I-VP O
with IN B-PP O
an DT B-NP O
insulin NN I-NP O
drip NN I-NP O
, , O O
which WDT B-NP O
oscillates VBZ B-VP O
between IN B-PP O
4-11 CD B-NP O
U/hr NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
being VBG I-VP O
fed VBN I-VP O
with IN B-PP O
Glucerna NNP B-NP O
continuous JJ I-NP O
TF NN I-NP O
at IN B-PP O
120 CD B-NP O
cc/hr NN I-NP O
, , O O
and CC O O
has VBZ B-VP O
been VBN I-VP O
started VBN I-VP O
on IN B-PP O
NPH NNP B-NP O
50 CD I-NP O
U NNP I-NP O
q12h NNP I-NP O
. . O O
PMH: . O O
1 CD B-LST O
. . O O
DM-2 '' O O
2. . B-NP O
HTN NNP I-NP O
3. DT B-NP O
Mixed NNP I-NP O
dyslipidemia NN I-NP O
4 CD B-LST O
. . O O
Depression NN O O
5 CD B-LST O
. . O O
Obesity NN O O
6 CD B-LST O
. . O O
Back RP B-VP O
pain NN I-VP O
7. DT B-NP O
Fourier NNP I-NP O
's POS B-NP O
gangrene NN I-NP O
as IN B-PP O
above IN O O
8. DT B-NP O
Hyponatremia NNP I-NP O
on IN B-PP O
HCTZ NNP B-NP O
ALL NNP B-NP O
: : O O
NKDA NNP O O
MEDS NNP B-NP O
PTA NNP I-NP O
: : O O
1 LS O O
. . O O
ASA NNP O O
81 CD B-NP O
daily NN I-NP O
2. DT B-NP O
Atenolol NNP I-NP O
100 CD I-NP O
qam NN I-NP O
, , O O
50 CD B-NP O
qpm NN I-NP O
3. CD B-NP O
Celexa NNP I-NP O
60 CD I-NP O
daily NN I-NP O
4 LS O O
. . O O
Fenofibrate VB B-VP O
145 CD B-NP O
daily JJ I-NP O
5 CD B-NP O
. . O O
Glipizide NNP B-NP O
10 CD B-NP O
bid NN I-NP O
6 CD B-NP O
. . O O
Klonopin NNP B-NP O
1 CD B-NP O
prn NN I-NP O
7. . B-NP O
Lantus NNPS I-NP O
insulin NN I-NP O
50 CD B-NP O
units NNS I-NP O
bedtime NN I-NP O
8. . B-NP O
Lipitor NNP I-NP O
80 CD I-NP O
daily JJ O O
9 CD B-NP O
. . O O
Lisinopril NNP B-NP O
40 CD I-NP O
daily JJ O O
10 CD B-NP O
. . O O
Losartan NNP B-NP O
25 CD I-NP O
daily JJ O O
11 CD B-NP O
. . O O
Metformin NNP B-NP O
1000 CD B-NP O
bid NN I-NP O
Current JJ B-NP O
MEDS NNS I-NP O
: : O O
1 LS O O
. . B-NP O
Insulin NNP I-NP O
gtt VBD B-VP O
4-11 CD B-NP O
U/hr NN I-NP O
2. . B-NP O
Lopressor NNP I-NP O
75 CD I-NP O
qid NN I-NP O
3. . B-NP O
Seroquel NNP I-NP O
25 CD I-NP O
bid NN I-NP O
4 CD B-LST O
. . O O
Nexium NNP B-NP O
40 CD I-NP O
daily JJ O O
5 CD B-NP O
. . O O
Celexa NNP B-NP O
60 CD B-NP O
daily NN I-NP O
6 CD B-NP O
. . O O
Vancomycin NNP B-NP O
2g CD I-NP O
IV NNP I-NP O
q12h . O O
7. CD B-NP O
Cefepime NNP I-NP O
2g CD I-NP O
IV NNP I-NP O
q12h . O O
8. DT B-NP O
Ativan NNP I-NP O
0.5 CD I-NP O
IV NNP I-NP O
q12h . O O
9 CD B-NP O
. . O O
Dilaudid NNP B-NP O
0.25 CD I-NP O
IV NNP I-NP O
q4h NN I-NP O
10 CD B-NP O
. . O O
Levofloxacin NNP B-NP O
750 CD I-NP O
mg NN I-NP O
IV NNP I-NP O
daily RB O O
11 CD B-NP O
. . O O
Lovenox NNP B-NP O
30 CD I-NP O
mg NN I-NP O
bid NN I-NP O
12 CD B-NP O
. . O O
NPH NNP B-NP O
50 CD I-NP O
units NNS I-NP O
q12h . O O
13 CD B-NP O
. . O O
Iron NNP B-NP O
sulfate NN I-NP O
300 CD B-NP O
tid NN I-NP O
HAB NNP B-NP O
: : O O
Tobacco NNP B-NP O
: : O O
denies VBZ O O
EtOH NNP B-NP O
: : O O
occasional JJ O O
RD NNP B-NP O
: : O O
denies VBZ O O
SH NNP B-NP O
: : O O
Works NNP B-VP O
as IN B-PP O
a DT B-NP O
Teacher NN I-NP B-PROFESSION
of IN B-PP I-PROFESSION
Persons NNP B-NP I-PROFESSION
with IN B-PP I-PROFESSION
Disabilities NNPS B-NP I-PROFESSION
. . O O
FH NNP B-NP O
: : O O
Father NNP B-NP O
had VBD B-VP O
an DT B-NP O
MI NNP I-NP O
in IN B-PP O
his PRP$ B-NP O
40 CD I-NP I-AGE
's POS B-NP I-AGE
. . O O
PE NN B-NP O
: : O O
VS NNP B-NP O
: : O O
T NNP B-NP O
100.2 CD I-NP O
P NNP I-NP O
95 CD I-NP O
BP NNP I-NP O
127/75 CD I-NP O
RR NNP B-NP O
18 CD I-NP O
O2 IN B-PP O
99 CD B-NP O
% NN I-NP O
2L IN B-PP O
NC NNP B-NP O
Wt NNP I-NP O
341 CD I-NP O
lbs NNS I-NP O
PTA NNP I-NP O
Gen NNP B-NP O
: : O O
Alert NNP B-NP O
, , I-NP O
calm NN I-NP O
, , I-NP O
comfortable JJ I-NP O
, , O O
NAD NNP B-NP O
; : O O
decreased VBN B-NP O
phonation NN I-NP O
but CC O O
understands VBZ B-VP O
and CC I-VP O
follows VBZ I-VP O
commands NNS B-NP O
HEENT NNP B-NP O
: : O O
NC/AT NN B-NP O
, , O O
EOMI NNP B-NP O
, , O O
PERRL NNP B-NP O
, , O O
OP NNP B-NP O
clear JJ I-NP O
, , I-NP O
dry JJ I-NP O
MM NNP I-NP O
, , O O
Anicteric NNP B-NP O
Neck NNP B-NP O
: : O O
Supple NNP B-NP O
, , O O
LAD NNP B-NP O
, , O O
carotids VBZ B-VP O
2+ JJ B-NP O
w/o NN I-NP O
bruits NNS I-NP O
Lungs NNP B-NP O
: : O O
CTA NNP B-NP O
B NNP I-NP O
( -LRB- I-NP O
anterior JJ I-NP O
exam NN I-NP O
) -RRB- O O
CV NNP B-NP O
: : O O
RRR NNP B-NP O
Nl NNP I-NP O
S1 NNP I-NP O
S2 NNP I-NP O
M/G/R . O O
Abdomen NNP B-NP O
: : O O
NABS NNP B-NP O
soft JJ I-NP O
ND NNP I-NP O
Ostomy NNP I-NP O
pink JJ I-NP O
with IN B-PP O
light JJ B-NP O
brown JJ I-NP O
stool NN I-NP O
Ext JJ B-NP O
: : O O
c/c/e NN B-NP O
DP NNP I-NP O
2+ CD I-NP O
B NNP I-NP O
Warm NNP I-NP O
and CC O O
well RB B-VP O
perfused VBN I-VP O
Neuro NNP B-NP O
: : O O
MS NNP B-NP O
: : O O
A&Ox3 DT B-NP O
Moves NNS I-NP O
all DT B-NP O
4 CD I-NP O
Data NNP B-NP O
02/28/2077 CD B-NP B-DATE
NA NNP I-NP O
143 CD I-NP O
, , O O
K NNP B-NP O
4.0, CD I-NP O
CL NN I-NP O
110 CD B-NP O
( -LRB- I-NP O
H) NNP I-NP O
, , O O
CO2 NNP B-NP O
23.0, CD I-NP O
BUN NNP B-NP O
28 CD I-NP O
( -LRB- I-NP O
H) NN I-NP O
, , O O
CRE NNP B-NP O
0.8 CD I-NP O
, , O O
GLU NNP B-NP O
101 CD I-NP O
02/28/2077 CD B-NP B-DATE
CA NNP I-NP O
9.3 CD I-NP O
, , O O
PHOS NNP B-NP O
3.3 CD I-NP O
, , O O
MG NNP B-NP O
1.6 CD I-NP O
02/27/2077 CD B-NP B-DATE
IC NN I-NP O
1.21 CD O O
02/28/2077 CD B-NP B-DATE
WBC NNP I-NP O
10.5 CD I-NP O
, , O O
RBC NNP B-NP O
3.11 CD I-NP O
( -LRB- I-NP O
L) NNP I-NP O
, , O O
HGB NN B-NP O
8.8 CD I-NP O
( -LRB- I-NP O
L) NN I-NP O
, , O O
HCT NNP B-NP O
26.1 CD I-NP O
( -LRB- I-NP O
L) NNP I-NP O
, , O O
MCV NNP B-NP O
84 CD I-NP O
, , O O
MCH NNP B-NP O
28.4 CD I-NP O
, , O O
MCHC NNP B-NP O
33.8 CD I-NP O
, , O O
PLT NNP B-NP O
351 CD I-NP O
( -LRB- I-NP O
H) NNP I-NP O
, , O O
RDW NNP B-NP O
17.6 CD I-NP O
( -LRB- O O
H) NN O O
02/26/2077 CD B-NP B-DATE
ALT/SGPT NNP I-NP O
26 CD I-NP O
, , O O
AST/SGOT NNP B-NP O
20 CD I-NP O
, , O O
ALKP NNP B-NP O
75 CD I-NP O
, , O O
TBILI RB B-ADVP O
0.3 CD B-NP O
, , O O
DBILI NNP B-NP O
0.1 CD I-NP O
02/13/2077 CD B-NP B-DATE
CHOL NNP I-NP O
124 CD I-NP O
, , O O
TRIG NNP B-NP O
346 CD I-NP O
( -LRB- O O
H) NN O O
02/07/2077 CD B-NP B-DATE
CHOL NNP I-NP O
106 CD I-NP O
, , O O
TRIG NNP B-NP O
226 CD I-NP O
( -LRB- O O
H) NN O O
02/04/2077 CD B-NP B-DATE
CHOL NNP I-NP O
141 CD I-NP O
, , O O
TRIG NNP B-NP O
478 CD I-NP O
( -LRB- I-NP O
H) NNP I-NP O
, , O O
HDL NNP B-NP O
13 CD I-NP O
( -LRB- I-NP O
L) NN I-NP O
, , O O
LDL NNP B-NP O
--, , O O
CHOL/HDL NNP B-NP O
10.8 CD I-NP O
02/10/2077 CD B-NP B-DATE
CORT NNP I-NP O
30.4 CD I-NP O
02/10/2077 CD B-NP B-DATE
CORT NNP I-NP O
13.6 CD I-NP O
12/20/2076 CD B-NP B-DATE
MALB NN I-NP O
286 CD B-NP O
( -LRB- I-NP O
*) NN I-NP O
, , O O
MALB/CRE NNP B-NP O
4132.9 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
12/20/2076 CD B-NP B-DATE
HGBA1C JJ I-NP O
11.3 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
08/30/2076 CD B-NP B-DATE
HGBA1C JJ I-NP O
10.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
06/20/2076 CD B-NP B-DATE
HGBA1C JJ I-NP O
11.4 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
03/26/2076 CC O B-DATE
HGBA1C JJ B-NP O
8.4 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
12/20/2075 CD B-NP B-DATE
HGBA1C JJ I-NP O
8.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
11/14/2075 CD B-NP B-DATE
HGBA1C JJ I-NP O
10.6 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Impression NN B-NP O
: : O O
33 CD B-NP B-AGE
y/o NN I-NP O
M NNP I-NP O
with IN B-PP O
DM-2 NNP B-NP O
requiring VBG I-NP O
insulin NN I-NP O
, , O O
uncontrolled JJ B-NP O
PTA NNP I-NP O
, , O O
here RB B-ADVP O
recovering VBG B-VP O
from IN B-PP O
Fournier NNP B-NP O
's POS B-NP O
gangrene NN I-NP O
, , O O
still RB B-ADVP O
in IN B-PP O
ICU NNP B-NP O
with IN B-PP O
multiple JJ B-NP O
IV NNP I-NP O
Abx NNP I-NP O
and CC O O
being VBG B-VP O
fed VBN I-VP O
with IN B-PP O
TF NNP B-NP O
, , O O
requiring VBG B-VP O
high JJ B-NP O
doses NNS I-NP O
of IN B-PP O
insulin NN B-NP O
both DT B-NP O
IV NNP I-NP O
and CC I-NP O
SQ. NNP I-NP O
Pt NNP B-NP O
's POS B-NP O
insulin NN I-NP O
requirement NN I-NP O
is VBZ B-VP O
very RB B-ADJP O
large JJ I-ADJP O
due JJ I-ADJP O
to TO B-PP O
1 CD B-NP O
) -RRB- I-NP O
marked VBN I-NP O
insulin NN I-NP O
resistance NN I-NP O
secondary JJ B-ADJP O
to TO B-PP O
obesity NN B-NP O
, , O O
2 CD B-NP O
) -RRB- I-NP O
ongoing JJ I-NP O
infection NN I-NP O
and CC O O
critical JJ B-NP O
illness NN I-NP O
, , O O
and CC O O
3 CD B-NP O
) -RRB- I-NP O
enteral NN I-NP O
TF. . O O
Would MD B-VP O
maintain VB I-VP O
on IN B-PP O
insulin NN B-NP O
drip NN I-NP O
while IN B-SBAR O
titrating VBG B-VP O
NPH NNP B-NP O
doses NNS I-NP O
upwards RB B-ADVP O
by IN B-PP O
10 CD B-NP O
U NNP I-NP O
q12h NNP I-NP O
each DT B-NP O
dose NN I-NP O
as RB B-ADJP O
long JJ I-ADJP O
as IN B-PP O
czi NN B-NP O
drip NN I-NP O
is VBZ B-VP O
needed VBN I-VP O
. . O O
Considering VBG B-VP O
his PRP$ B-NP O
current JJ I-NP O
requirement NN I-NP O
of IN B-PP O
at IN B-NP O
least JJS I-NP O
120 CD I-NP O
U NNP I-NP O
IV/24h NNP I-NP O
on IN B-PP O
top NN B-NP O
of IN B-PP O
his PRP$ B-NP O
SQ NN I-NP O
doses NNS I-NP O
, , O O
he PRP B-NP O
will MD B-VP O
probably RB I-VP O
need VB I-VP O
close RB B-ADVP O
to TO B-PP O
100 CD B-NP O
U NNP I-NP O
q12h NN I-NP O
. . O O
Could MD B-VP O
safely RB I-VP O
increase VB I-VP O
his PRP$ B-NP O
NPH NNP I-NP O
to TO B-VP O
80 CD B-NP O
U NNP I-NP O
q12h NN I-NP O
right RB B-ADVP O
now RB I-ADVP O
. . O O
Would MD B-VP O
make VB I-VP O
sure JJ B-ADJP O
that IN B-SBAR O
in IN B-PP O
the DT B-NP O
Instructions NNS I-NP O
to TO B-PP O
this DT B-NP O
order NN I-NP O
it PRP B-NP O
's VBZ B-VP O
written VBN I-VP O
to TO I-VP O
hold VB I-VP O
NPH NNP B-NP O
if IN B-PP O
TF NNP B-NP O
stop NN I-NP O
for IN B-PP O
any DT B-NP O
reason NN I-NP O
, , O O
and CC O O
start VB B-VP O
D10W NNP B-NP O
@ IN B-PP O
50 CD B-NP O
cc/hr NN I-NP O
for IN B-PP O
12h JJ B-NP O
after IN B-PP O
the DT B-NP O
last JJ I-NP O
NPH NNP I-NP O
dose NN I-NP O
if IN B-SBAR O
that DT B-NP O
happens VBZ B-VP O
. . O O
Recommend NNP B-NP O
: : O O
1 LS B-NP O
. . O O
Increase VB B-VP O
NPH RB B-ADVP O
to TO B-PP O
80 CD B-NP O
U NNP I-NP O
q12h . O O
2. DT B-NP O
Titrate NNP I-NP O
NPH NNP I-NP O
doses VBZ B-VP O
upwards RB B-ADVP O
by IN B-PP O
10 CD B-NP O
U NNP I-NP O
q12h NNP I-NP O
each DT B-NP O
dose NN I-NP O
as RB B-ADJP O
long JJ I-ADJP O
as IN B-PP O
czi NN B-NP O
drip NN I-NP O
is VBZ B-VP O
needed VBN I-VP O
3. PRP B-NP O
Please VB B-VP O
make VB I-VP O
sure JJ B-ADJP O
that IN B-SBAR O
in IN B-PP O
the DT B-NP O
Instructions NNS I-NP O
to TO B-PP O
the DT B-NP O
NPH NNP I-NP O
order NN I-NP O
it PRP B-NP O
's VBZ B-VP O
written VBN I-VP O
to TO I-VP O
hold VB I-VP O
NPH NNP B-NP O
if IN B-PP O
TF NNP B-NP O
stop NN I-NP O
for IN B-PP O
any DT B-NP O
reason NN I-NP O
, , O O
and CC O O
start VB B-VP O
D10W NNP B-NP O
@ IN B-PP O
50 CD B-NP O
cc/hr NN I-NP O
for IN B-PP O
12h JJ B-NP O
after IN B-PP O
the DT B-NP O
last JJ I-NP O
NPH NNP I-NP O
dose NN I-NP O
(especially RB B-ADVP O
if IN B-PP O
pt JJ B-NP O
transfers NNS I-NP O
to TO B-PP O
floor NN B-NP O
) -RRB- O O
4 CD B-LST O
. . O O
Would MD B-VP O
consider VB I-VP O
reintroducing VBG I-VP O
ACEi NNP B-NP O
for IN B-PP O
kidney NN B-NP O
protection NN I-NP O
into IN B-PP O
his PRP$ B-NP O
BP NNP I-NP O
regimen NNS I-NP O
( -LRB- I-NP O
e NN I-NP O
.g NN I-NP O
. . O O
Lisinopril NNP B-NP O
10 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
) -RRB- I-NP O
5 CD B-NP O
. . O O
Pt NNP B-NP O
will MD B-VP O
likely RB I-VP O
need VB I-VP O
fibrate JJ B-ADJP O
for IN B-PP O
hypertriglyceridemia NN B-NP O
as IN B-SBAR O
he PRP B-NP O
improves VBZ B-LST O
Thank VB B-VP O
you PRP B-NP O
for IN B-PP O
interesting JJ B-NP O
consult VB I-NP O
Dr. NNP B-NP O
Tan NNP I-NP B-DOCTOR
will MD B-VP O
follow VB I-VP O
Uriel NNP B-NP B-DOCTOR
J. NNP I-NP I-DOCTOR
Pierson NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
, , O O
PhD NNP B-NP O
Pager NNP B-NP O
# # I-NP O
77198 CD O B-PHONE
